Deerfield Management Company, L.P. (Series C) ALNYLAM PHARMACEUTICALS INC Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Number of Shares
110,000,000
Previous 110,000,000
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%